Source: Eur Respir J 2009; 34: 616
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Klagas I., Goulet S., Karakiulakis G., Zhong J., Baraket M., Black J. L., Papakonstantinou E., Roth M.. Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD. Eur Respir J 2009; 34: 616

Member's Comments

No comment yet.

Related content which might interest you: Decreased hyaluronan in airway smooth muscle cells of asthma and COPD patients Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of COPD Year: 2009 Irisin stimulates the secretion of hyaluronic acid by airway smooth muscle cells from patients with chronic obstructive pulmonary disease Source: International Congress 2017 – Therapeutic approaches in lung disease Year: 2017 Corticosteroids and beta2-agonists modify hyaluronic acid homeostasis in human airway smooth muscle cells in asthma and COPD Source: Annual Congress 2009 - Translational research/biomarkers Year: 2009 Contractility of bronchial smooth muscle and changes during disease Source: Annual Congress 2005 - Role of the bronchial smooth muscle in regulating airway disease Year: 2005 Fibronectin content in airway smooth muscle in fatal asthma Source: Eur Respir J 2006; 28: Suppl. 50, 217s Year: 2006 Treating asthma means treating airway smooth muscle cells Source: Eur Respir J 2008; 32: 265-274 Year: 2008 Mast cells in COPD airways: relationship to bronchodilator responsiveness and angiogenesis Source: Eur Respir J 2012; 39: 1361-1367 Year: 2012 Corticosteroids and beta2-agonists regulate pathologic homeostasis of hyaluronic acid in human airway smooth muscle cells from patients with asthma and COPD. Therapeutic relevance Source: Annual Congress 2010 - Airway cells as targets for anti-inflammatory drugs Year: 2010 Airway smooth muscle remodeling in children with asthma, cystic fibrosis and bronchiectasis Source: Annual Congress 2007 - Pathophysiology of childhood asthma: new insights Year: 2007 Correlation between airway smooth muscle (ASM) and eosinophilic inflammation in severe non-controlled asthmatics Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012 Corticosteroid insensitivity in airway smooth muscle cells of severe asthma and COPD: Modulation by IFN-γ Source: Annual Congress 2012 - Basic and translational studies in COPD Year: 2012 Long-term effects of bronchial thermoplasty on airway smooth muscle and collagen deposition in severe asthma Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016 Relationship between the tissue depletion pattern and muscle mass, muscle strength and inflammation in COPD patients Source: Annual Congress 2006 - COPD and systemic inflammation Year: 2006 Airway smooth muscle cells phenotype modulation in chronical obstructive type of lung insufficiency Source: Eur Respir J 2003; 22: Suppl. 45, 455s Year: 2003 Pathophysiology of bronchial smooth muscle remodelling in asthma Source: Eur Respir J 2010; 36: 1174-1184 Year: 2010 The novel compound Sul-121 inhibits inflammation in experimental models of chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Distribution of increased airway smooth muscle thickness and airway inflammation in asthma Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Airway epithelial inflammatory responses and clinical parameters in COPD Source: Eur Respir J 2003; 22: 94-99 Year: 2003 The critical role of bronchial smooth muscle remodeling in non-severe asthma Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015